DI STEFANO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 571
EU - Europa 454
AS - Asia 126
AF - Africa 1
Totale 1.152
Nazione #
US - Stati Uniti d'America 567
IE - Irlanda 156
SE - Svezia 125
CN - Cina 74
UA - Ucraina 57
KR - Corea 41
DE - Germania 37
GB - Regno Unito 36
FI - Finlandia 20
BE - Belgio 7
IT - Italia 7
IN - India 6
CA - Canada 3
RU - Federazione Russa 3
FR - Francia 2
MY - Malesia 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
Totale 1.152
Città #
Dublin 156
Jacksonville 112
Chandler 95
Ashburn 74
Nyköping 63
Beijing 41
Lancaster 26
Princeton 20
Cambridge 19
Medford 18
Boardman 17
Ann Arbor 15
Wilmington 14
Dearborn 12
Des Moines 12
Washington 9
Brussels 7
New York 7
Woodbridge 7
Hebei 5
Falls Church 4
Shenyang 4
Hangzhou 3
Jiaxing 3
Ningbo 3
Pune 3
San Mateo 3
Guangzhou 2
Houston 2
Jinan 2
Leawood 2
Los Angeles 2
Mumbai 2
Nanjing 2
Norwalk 2
Ottawa 2
Seattle 2
Tianjin 2
Aci Sant'antonio 1
Bangalore 1
Bremen 1
Brno 1
Budapest 1
Caianello 1
Changsha 1
Clearwater 1
Haikou 1
Helsinki 1
Incheon 1
Kamampa 1
Kharkov 1
Kunming 1
Messina 1
Mexico City 1
Novokuznetsk 1
Riva 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Toronto 1
Turin 1
Warsaw 1
Zhengzhou 1
Totale 799
Nome #
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate 85
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 83
A NEW MELANOCORTIN AGONIST REDUCES CERULEIN INDUCED PANCREATIC DAMAGE IN AN EXPERIMENTAL RAT MODEL 78
Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. 68
Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages 67
null 64
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 60
EFFECTS OF PDRN ON SPERMATOGENETIC ACTIVITY DURING THE PROGRESSION OF TESTICULAR ISCHEMIA AND REPERFUSION IN RATS 60
Effects of Soy Isoflavone Genistein Aglycone On Skin Changes Induced By Experimental Menopause : A Comparison With Estradiol And Raloxifene 58
FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX, REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL MODEL OF ACUTE PANCREATITIS. 57
Peroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injury. 54
GENISTEIN AGLYCONE DEMONSTRATES A PROTECTIVE AND REVERSIBLE EFFECT ON THE DEVELOPMENT OF STEROID-INDUCED SECONDARY OSTEOPOROSIS AND INCREASES BONE BREAKING STRENGHT IN VIVO 54
EFFECTS OF AGLYCONE GENISTEIN IN A RAT EXPERIMENTAL MODEL OF POSTMENOPAUSAL METABOLIC SYNDROME 51
MELANOCORTINS PROTECT AGAINST CENTRAL AND PERIPHERAL DAMAGE FOLLOWING CEREBRAL ISCHEMIA THROUGH A VAGUS NERVE-MEDIATED MECHANISM 50
Mitogen-activated protein kinase 3/mitogen-activated protein kinase 1 activates apoptosis during testicular ischemia-reperfusion injury in a nuclear factor-kappaB-independent manner. 48
TREHALOSE: A UNIC SUGAR THAT PROTECT AGAINST ENDOTOXIC SHOCK. 47
Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268. 45
Efficacy of genistein aglycone on some cardiovascular risk factors: a follow-up study 44
ZIF268 GENE INVOLVEMENT IN MELANOCORTIN-INDUCED LONG-LASTING FUNCTIONAL RECOVERY FROM ISCHEMIC STROKE 44
Rituximab in AChR subtype of myasthenia gravis: systematic review 32
Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats 7
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 5
Totale 1.161
Categoria #
all - tutte 3.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 1 1 0 1
2019/2020179 32 18 1 7 0 14 22 24 2 38 20 1
2020/2021112 19 0 32 3 2 18 1 15 0 7 12 3
2021/2022157 1 28 2 2 6 4 3 8 3 46 13 41
2022/2023420 27 30 26 33 25 34 2 20 193 4 18 8
2023/2024127 7 11 4 37 25 42 0 0 1 0 0 0
Totale 1.161